Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Erin Schenk

Concepts (195)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
30
2026
2674
3.560
Why?
Carcinoma, Non-Small-Cell Lung
22
2026
1194
3.300
Why?
Platinum
1
2019
48
0.590
Why?
ErbB Receptors
6
2024
636
0.550
Why?
Antineoplastic Combined Chemotherapy Protocols
7
2024
1996
0.530
Why?
Tumor Microenvironment
6
2022
745
0.490
Why?
Neoplasm Staging
6
2026
1486
0.460
Why?
Mutation
6
2024
4082
0.460
Why?
B7-H1 Antigen
3
2026
245
0.440
Why?
Biomarkers, Tumor
9
2026
1334
0.440
Why?
Sarcoma
1
2017
209
0.420
Why?
Protein Kinase Inhibitors
5
2026
982
0.420
Why?
Acrylamides
2
2024
74
0.410
Why?
Aniline Compounds
2
2024
120
0.400
Why?
Proto-Oncogene Proteins p21(ras)
2
2024
250
0.380
Why?
Cytarabine
1
2012
66
0.360
Why?
Immunotherapy
5
2026
669
0.320
Why?
Protein Kinases
1
2012
311
0.320
Why?
Neoplasms
4
2026
2944
0.310
Why?
Neoadjuvant Therapy
2
2024
474
0.280
Why?
Pyrimidines
4
2024
530
0.270
Why?
Cell Cycle Proteins
1
2012
629
0.270
Why?
Humans
39
2026
145625
0.270
Why?
CD3 Complex
1
2026
112
0.230
Why?
Antineoplastic Agents
4
2024
2218
0.230
Why?
Survival Rate
5
2026
2078
0.230
Why?
Leukemia, Myeloid, Acute
1
2012
700
0.220
Why?
Small Cell Lung Carcinoma
1
2026
125
0.210
Why?
Pemetrexed
1
2024
40
0.210
Why?
Zinc Finger Protein Gli2
1
2024
4
0.210
Why?
Cell Line, Tumor
4
2024
3538
0.210
Why?
Antigens, Neoplasm
1
2026
271
0.210
Why?
Proto-Oncogene Proteins c-met
1
2024
76
0.200
Why?
Oncogenes
1
2024
113
0.200
Why?
Neoplasm Proteins
1
2026
443
0.190
Why?
Oncogene Addiction
1
2023
6
0.190
Why?
Practice Guidelines as Topic
3
2026
1581
0.180
Why?
Receptors, Antigen, T-Cell
1
2026
676
0.180
Why?
Bevacizumab
1
2023
167
0.180
Why?
Aged, 80 and over
6
2026
8351
0.170
Why?
Receptors, Purinergic P1
1
2021
30
0.170
Why?
High-Throughput Nucleotide Sequencing
1
2024
538
0.160
Why?
Carcinoma, Pancreatic Ductal
1
2024
297
0.160
Why?
Carbon Monoxide
1
2020
82
0.160
Why?
Major Histocompatibility Complex
1
2021
233
0.160
Why?
Benzimidazoles
1
2021
189
0.160
Why?
Etoposide
2
2019
169
0.150
Why?
Quinazolines
1
2021
267
0.150
Why?
Organophosphorus Compounds
1
2020
84
0.150
Why?
Aged
10
2026
26251
0.150
Why?
Protein-Tyrosine Kinases
1
2023
429
0.150
Why?
Picornaviridae
1
2019
18
0.150
Why?
Proto-Oncogene Proteins
1
2023
615
0.150
Why?
Diagnostic Imaging
1
2022
340
0.150
Why?
Adenosine
1
2021
255
0.150
Why?
Carboplatin
1
2019
168
0.140
Why?
Nuclear Proteins
2
2024
739
0.140
Why?
Histocompatibility Antigens Class II
1
2020
365
0.140
Why?
Cisplatin
2
2019
346
0.140
Why?
Gene Expression Regulation, Neoplastic
1
2024
1429
0.130
Why?
Maximum Tolerated Dose
2
2021
216
0.130
Why?
Middle Aged
11
2026
36359
0.130
Why?
Adaptive Immunity
1
2019
172
0.130
Why?
Trans-Activators
1
2020
371
0.130
Why?
Lymphocyte Count
1
2017
166
0.130
Why?
Male
13
2026
73014
0.120
Why?
Antineoplastic Agents, Immunological
1
2019
200
0.120
Why?
Antigens, CD19
1
2017
137
0.120
Why?
Complement Activation
1
2019
412
0.120
Why?
Pancreatic Neoplasms
1
2024
944
0.110
Why?
Interferon-gamma
1
2019
780
0.110
Why?
Indoles
3
2024
509
0.110
Why?
Female
12
2026
79080
0.110
Why?
ROC Curve
1
2017
613
0.110
Why?
Genomics
1
2020
851
0.110
Why?
Influenza Vaccines
1
2020
541
0.110
Why?
CD8-Positive T-Lymphocytes
1
2021
929
0.110
Why?
Molecular Targeted Therapy
3
2026
446
0.110
Why?
Double-Blind Method
1
2019
2064
0.100
Why?
Monocytes
1
2017
538
0.100
Why?
Drug Resistance, Neoplasm
1
2019
889
0.100
Why?
Dose-Response Relationship, Drug
2
2021
2018
0.100
Why?
Brain Neoplasms
1
2023
1324
0.100
Why?
Bortezomib
1
2013
54
0.100
Why?
Boronic Acids
1
2013
37
0.090
Why?
Immunohistochemistry
3
2022
1709
0.090
Why?
Lactams, Macrocyclic
1
2013
51
0.090
Why?
Benzoquinones
1
2013
46
0.090
Why?
Checkpoint Kinase 1
1
2012
27
0.090
Why?
Ataxia Telangiectasia Mutated Proteins
1
2012
69
0.090
Why?
Mass Screening
1
2020
1300
0.090
Why?
Pyrazines
1
2013
94
0.090
Why?
Cell Cycle Checkpoints
1
2012
97
0.090
Why?
Molecular Chaperones
3
2002
200
0.090
Why?
B7-1 Antigen
2
2008
55
0.090
Why?
Medical Oncology
2
2024
344
0.080
Why?
Prognosis
3
2026
4331
0.080
Why?
Treatment Outcome
3
2026
11744
0.070
Why?
Adult
7
2026
40821
0.070
Why?
Pyrazoles
1
2012
516
0.070
Why?
Mice
7
2026
18266
0.070
Why?
Prospective Studies
1
2020
8087
0.070
Why?
Interleukin-17
1
2008
121
0.070
Why?
Programmed Cell Death 1 Receptor
2
2020
268
0.060
Why?
Forkhead Transcription Factors
1
2008
208
0.060
Why?
Randomized Controlled Trials as Topic
2
2024
1754
0.060
Why?
Neoplasms, Experimental
1
2007
163
0.060
Why?
T-Lymphocytes, Cytotoxic
1
2007
180
0.060
Why?
Antibodies
1
2008
395
0.060
Why?
Immunoglobulin M
1
2007
284
0.060
Why?
Gene Rearrangement
1
2026
155
0.050
Why?
T-Lymphocytes, Regulatory
1
2008
411
0.050
Why?
Flow Cytometry
3
2022
1160
0.050
Why?
Antiporters
2
2002
22
0.050
Why?
T-Lymphocyte Subsets
1
2007
415
0.050
Why?
Cell Proliferation
1
2012
2497
0.050
Why?
Immunoglobulins
2
2002
162
0.050
Why?
Retrospective Studies
4
2024
17291
0.050
Why?
Apoptosis
1
2012
2436
0.050
Why?
DNA Copy Number Variations
1
2024
189
0.050
Why?
Histocompatibility Antigens Class I
2
2002
207
0.050
Why?
Lymphocyte Activation
1
2007
1136
0.050
Why?
Animals
7
2026
38030
0.050
Why?
Carcinogenesis
1
2024
226
0.050
Why?
Autoimmunity
1
2008
924
0.040
Why?
HLA-A Antigens
1
2002
52
0.040
Why?
Neoplasm Metastasis
1
2024
693
0.040
Why?
HLA-B Antigens
1
2002
58
0.040
Why?
Vascular Endothelial Growth Factors
1
2021
77
0.040
Why?
Mitogen-Activated Protein Kinase Kinases
1
2021
126
0.040
Why?
Cell Line
3
2020
2809
0.040
Why?
Cluster Analysis
1
2022
494
0.040
Why?
Central Nervous System
1
2023
278
0.040
Why?
Promoter Regions, Genetic
1
2024
1236
0.040
Why?
Suppressor of Cytokine Signaling 1 Protein
1
2019
12
0.040
Why?
Drug Administration Schedule
1
2021
782
0.040
Why?
Gene Amplification
1
2019
116
0.040
Why?
Polymorphism, Genetic
1
2002
611
0.040
Why?
Chemokine CXCL9
1
2019
38
0.040
Why?
Complement C5a
1
2019
54
0.040
Why?
Complement C3a
1
2019
40
0.040
Why?
Mice, Transgenic
1
2024
2131
0.040
Why?
Disease Models, Animal
2
2020
4565
0.040
Why?
Histones
1
2024
670
0.040
Why?
Gene Silencing
1
2019
200
0.030
Why?
Programmed Cell Death 1 Ligand 2 Protein
2
2008
14
0.030
Why?
Complement Inactivating Agents
1
2019
78
0.030
Why?
Sequence Analysis, RNA
1
2020
441
0.030
Why?
Transcription, Genetic
1
2024
1429
0.030
Why?
Single-Cell Analysis
1
2020
366
0.030
Why?
Disease Progression
1
2024
2857
0.030
Why?
Carcinoma, Small Cell
1
1997
172
0.030
Why?
Ecosystem
1
2020
483
0.030
Why?
Interferon Type I
1
1997
147
0.030
Why?
Carcinoma, Squamous Cell
1
2019
627
0.030
Why?
Antibodies, Monoclonal, Humanized
1
2020
992
0.020
Why?
Macrophages
1
2020
1530
0.020
Why?
T-Lymphocytes
1
2020
2007
0.020
Why?
Membrane Transport Proteins
2
2002
153
0.020
Why?
Magnetic Resonance Imaging
1
2023
3917
0.020
Why?
Follow-Up Studies
1
2019
5397
0.020
Why?
Mice, Inbred C57BL
1
2020
6021
0.020
Why?
T-Cell Antigen Receptor Specificity
1
2008
45
0.020
Why?
Perforin
1
2007
22
0.020
Why?
Pore Forming Cytotoxic Proteins
1
2007
15
0.020
Why?
Cell Communication
1
2008
327
0.010
Why?
Immune Tolerance
1
2008
384
0.010
Why?
Dendritic Cells
1
2008
507
0.010
Why?
Multiple Myeloma
1
2008
310
0.010
Why?
Membrane Glycoproteins
1
2007
495
0.010
Why?
Vaccines
1
2008
389
0.010
Why?
HLA-B15 Antigen
1
2002
12
0.010
Why?
Histidine
1
2002
66
0.010
Why?
Aspartic Acid
1
2002
88
0.010
Why?
Glutamine
1
2002
110
0.010
Why?
Substrate Specificity
1
2002
387
0.010
Why?
CD4-Positive T-Lymphocytes
1
2007
1148
0.010
Why?
Antigen Presentation
1
2002
209
0.010
Why?
Structure-Activity Relationship
1
2002
561
0.010
Why?
Cytokines
1
2008
2079
0.010
Why?
Ligands
1
2002
676
0.010
Why?
Transfection
1
2002
914
0.010
Why?
Blotting, Western
1
2002
1176
0.010
Why?
RNA, Messenger
1
2007
2783
0.010
Why?
Protein Conformation
1
2002
914
0.010
Why?
Amino Acids
1
2002
513
0.010
Why?
Models, Molecular
1
2002
1571
0.010
Why?
Vincristine
1
1997
148
0.010
Why?
Cyclophosphamide
1
1997
275
0.010
Why?
B-Lymphocytes
1
2002
884
0.010
Why?
Peptides
1
2002
991
0.010
Why?
Remission Induction
1
1997
308
0.010
Why?
Protein Binding
1
2002
2239
0.010
Why?
Doxorubicin
1
1997
414
0.010
Why?
Recombinant Proteins
1
1997
1361
0.010
Why?
Schenk's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)